Codes / ICD10CM / E09.3491

E09.3491 Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug or Chemical Induced Diabetes Mellitus with Severe Nonproliferative Diabetic Retinopathy Without Macular Edema, Right Eye (ICD-10 Code: E09.3491)

Summary

Drug or chemical induced diabetes mellitus with severe nonproliferative diabetic retinopathy without macular edema, right eye, is a condition where elevated blood sugar levels, caused by exposure to specific medications or chemicals, lead to advanced eye complications affecting the right eye. This form of diabetes is directly attributable to external factors that disrupt glucose metabolism, resulting in hyperglycemia and associated retinal damage. The retinopathy is classified as severe nonproliferative without macular edema, meaning it involves significant retinal changes without abnormal blood vessel growth and does not include swelling in the macula of the right eye.

Causes

The condition is caused by exposure to drugs or chemicals that impair glucose regulation, leading to uncontrolled hyperglycemia. Common culprits include medications (e.g., glucocorticoids, antipsychotics, or diuretics) and toxins that reduce insulin secretion or increase insulin resistance. These substances trigger hyperglycemia, which, if untreated, progresses to severe nonproliferative diabetic retinopathy without macular edema due to damage to blood vessels in the retina of the right eye.

Risk Factors

  • Use of medications known to affect glucose metabolism (e.g., steroids, antiretrovirals).
  • Exposure to chemicals or toxins that disrupt endocrine function.
  • Pre-existing metabolic conditions that increase susceptibility to hyperglycemia.
  • Prolonged or high-dose exposure to glucose-altering substances.
  • Uncontrolled blood sugar levels due to external factors.

Symptoms

  • Blurred vision in the right eye.
  • Difficulty seeing in low light or at night.
  • Floaters or spots in the visual field of the right eye.
  • Reduced color perception in the right eye.
  • Gradual vision loss in the right eye without sudden changes.

Diagnosis

Diagnosis involves a comprehensive eye examination, including a dilated retinal exam to assess the right eye for signs of severe nonproliferative diabetic retinopathy without macular edema. Imaging tests, such as optical coherence tomography (OCT) or fluorescein angiography, may be used to evaluate retinal structure and blood flow. Blood tests to confirm hyperglycemia and identify the causative drug or chemical are also performed. A detailed patient history, including medication use and exposure to toxins, is critical for linking the retinopathy to external factors.

Treatment Options

Treatment focuses on managing blood sugar levels to prevent further retinal damage, often by discontinuing or adjusting the causative drug or chemical. Glycemic control through diet, exercise, or medication may be recommended. For retinopathy, regular monitoring and laser therapy or anti-VEGF injections may be considered if progression occurs. Vision rehabilitation and lifestyle modifications, such as smoking cessation and blood pressure control, are also important.

Prognosis and Follow-Up

Prognosis depends on the extent of retinal damage and the effectiveness of glycemic control. With proper management, progression can be slowed, but existing damage may be irreversible. Regular follow-up with an ophthalmologist is essential to monitor the right eye for changes. Long-term care may involve ongoing blood sugar management and periodic retinal evaluations to prevent complications.

Complications

  • Progression to proliferative diabetic retinopathy, which may involve abnormal blood vessel growth.
  • Macular edema, leading to further vision loss.
  • Permanent vision impairment or blindness in the right eye.
  • Increased risk of other diabetes-related complications, such as kidney or nerve damage.

Lifestyle & Prevention

  • Avoid or limit exposure to medications or chemicals known to affect glucose metabolism.
  • Maintain a balanced diet and regular exercise to support overall metabolic health.
  • Monitor blood sugar levels closely if using glucose-altering substances.
  • Quit smoking and limit alcohol intake to reduce additional stress on the eyes.
  • Attend regular eye exams, especially if at risk for diabetes or retinopathy.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision changes, increased floaters, or pain in the right eye. Contact a healthcare provider if you notice persistent blurriness, difficulty seeing, or other visual disturbances, as early intervention can help prevent further damage.

Tips for Medical Coders

When coding E09.3491, ensure the documentation specifies the right eye involvement and confirms the absence of macular edema. Verify that the retinopathy is classified as severe nonproliferative and that the diabetes is drug or chemical induced. Include details about the causative agent and any related treatments in the record to support accurate coding.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

E09.3491 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.